Načítá se...
Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy
The recent tremendous successes in clinical trials take cancer immunotherapy into a new era and have attracted major attention from both academia and industry. Among the variety of immunotherapy strategies developed to boost patients’ own immune systems to fight against malignant cells, the pathogen...
Uloženo v:
| Vydáno v: | Immunotherapy |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5941714/ https://ncbi.nlm.nih.gov/pubmed/28877635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2017-0055 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|